These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 27489136)

  • 1. Multifunctional T Cell Response to DosR and Rpf Antigens Is Associated with Protection in Long-Term Mycobacterium tuberculosis-Infected Individuals in Colombia.
    Arroyo L; Rojas M; Franken KL; Ottenhoff TH; Barrera LF
    Clin Vaccine Immunol; 2016 Oct; 23(10):813-824. PubMed ID: 27489136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell responses to DosR and Rpf proteins in actively and latently infected individuals from Colombia.
    Riaño F; Arroyo L; París S; Rojas M; Friggen AH; van Meijgaarden KE; Franken KL; Ottenhoff TH; García LF; Barrera LF
    Tuberculosis (Edinb); 2012 Mar; 92(2):148-59. PubMed ID: 22226907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of DosR and Rpf antigens from Mycobacterium tuberculosis to discriminate between latent and active tuberculosis in a tuberculosis endemic population of Medellin Colombia.
    Arroyo L; Marín D; Franken KLMC; Ottenhoff THM; Barrera LF
    BMC Infect Dis; 2018 Jan; 18(1):26. PubMed ID: 29310595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of the T cell response to Mycobacterium tuberculosis DosR and Rpf antigens in a Colombian population of household contacts of recently diagnosed pulmonary tuberculosis patients.
    Arroyo L; Rojas M; Ortíz BL; Franken KL; García LF; Ottenhoff TH; Barrera LF
    Tuberculosis (Edinb); 2016 Mar; 97():97-107. PubMed ID: 26980501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double- and monofunctional CD4⁺ and CD8⁺ T-cell responses to Mycobacterium tuberculosis DosR antigens and peptides in long-term latently infected individuals.
    Commandeur S; Lin MY; van Meijgaarden KE; Friggen AH; Franken KL; Drijfhout JW; Korsvold GE; Oftung F; Geluk A; Ottenhoff TH
    Eur J Immunol; 2011 Oct; 41(10):2925-36. PubMed ID: 21728172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-Mediated Immune Responses to
    Coppola M; Villar-Hernández R; van Meijgaarden KE; Latorre I; Muriel Moreno B; Garcia-Garcia E; Franken KLMC; Prat C; Stojanovic Z; De Souza Galvão ML; Millet JP; Sabriá J; Sánchez-Montalva A; Noguera-Julian A; Geluk A; Domínguez J; Ottenhoff THM
    Front Immunol; 2020; 11():103. PubMed ID: 32117257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of late stage specific peptide antigens of Mycobacterium tuberculosis.
    Singh M; Bhatt P; Sharma M; Varma-Basil M; Chaudhry A; Sharma S
    Infect Genet Evol; 2019 Oct; 74():103930. PubMed ID: 31228643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rv2204c, Rv0753c and Rv0009 antigens specific T cell responses in latent and active TB - a flow cytometry-based analysis.
    Pathakumari B; Devasundaram S; Maddineni P; Raja A
    Int J Med Microbiol; 2018 Mar; 308(2):297-305. PubMed ID: 29325881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-γ responses to Mycobacterium tuberculosis Rpf proteins in contact investigation.
    Huang W; Qi Y; Ren C; Wen H; Franken KL; Ottenhoff TH; Shen J
    Tuberculosis (Edinb); 2013 Nov; 93(6):612-7. PubMed ID: 24053975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of CD4 and CD8 T cells producing IFN-γ in human latent and active tuberculosis.
    Rueda CM; Marín ND; García LF; Rojas M
    Tuberculosis (Edinb); 2010 Nov; 90(6):346-53. PubMed ID: 20933471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis.
    Singh S; Saraav I; Sharma S
    Vaccine; 2014 Feb; 32(6):712-6. PubMed ID: 24300592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DosR proteins of Mycobacterium tuberculosis upregulate effector T cells and down regulate T regulatory cells in TB patients and their healthy contacts.
    Pandey K; Singh S; Bhatt P; Medha ; Sharma M; Chaudhry A; Sharma S
    Microb Pathog; 2019 Jan; 126():399-406. PubMed ID: 30476579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of dormancy-related antigens in individuals infected with Mycobacterium tuberculosis in Japan.
    Hozumi H; Tsujimura K; Yamamura Y; Seto S; Uchijima M; Nagata T; Miwa S; Hayakawa H; Fujisawa T; Hashimoto D; Inui N; Suda T; Chida K; Koide Y
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):818-24. PubMed ID: 23676169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of CD27 and CCR4 Markers on Specific CD4
    Latorre I; Fernández-Sanmartín MA; Muriel-Moreno B; Villar-Hernández R; Vila S; Souza-Galvão ML; Stojanovic Z; Jiménez-Fuentes MÁ; Centeno C; Ruiz-Manzano J; Millet JP; Molina-Pinargote I; González-Díaz YD; Lacoma A; Luque-Chacón L; Sabriá J; Prat C; Domínguez J
    Front Immunol; 2018; 9():3094. PubMed ID: 30687314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequencies of region of difference 1 antigen-specific but not purified protein derivative-specific gamma interferon-secreting T cells correlate with the presence of tuberculosis disease but do not distinguish recent from remote latent infections.
    Hinks TS; Dosanjh DP; Innes JA; Pasvol G; Hackforth S; Varia H; Millington KA; Liu XQ; Bakir M; Soysal A; Davidson RN; Gunatheesan R; Lalvani A
    Infect Immun; 2009 Dec; 77(12):5486-95. PubMed ID: 19752037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD137 is a Useful Marker for Identifying CD4
    Yan ZH; Zheng XF; Yi L; Wang J; Wang XJ; Wei PJ; Jia HY; Zhou LJ; Zhao YL; Zhang HT
    Scand J Immunol; 2017 May; 85(5):372-380. PubMed ID: 28218958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cytokine profiles related to
    Yasuda I; Saludar NRD; Sayo AR; Suzuki S; Yokoyama A; Ozeki Y; Kobayashi H; Nishiyama A; Matsumoto S; Cox SE; Tanaka T; Yamashita Y
    Front Immunol; 2024; 15():1330796. PubMed ID: 38665909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of profile and functionality of memory T cells in pulmonary tuberculosis.
    Tonaco MM; Moreira JD; Nunes FFC; Loures CMG; Souza LR; Martins JM; Silva HR; Porto AHR; Toledo VPCP; Miranda SS; Guimarães TMPD
    Immunol Lett; 2017 Dec; 192():52-60. PubMed ID: 29106984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
    Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
    Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells.
    Lindenstrøm T; Agger EM; Korsholm KS; Darrah PA; Aagaard C; Seder RA; Rosenkrands I; Andersen P
    J Immunol; 2009 Jun; 182(12):8047-55. PubMed ID: 19494330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.